These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9553754)

  • 1. Characteristics of biochemical markers in patients with metabolic bone disorders.
    Hoshino H; Kushida K; Takahashi M; Kawana K; Denda M; Yamazaki K; Inoue T
    Endocr Res; 1998 Feb; 24(1):55-64. PubMed ID: 9553754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of biochemical markers in patients with ossification of posterior longitudinal ligament of the spine.
    Ishihara C; Kushida K; Takahashi M; Ohishi T; Murata H; Nagano A; Goto S
    Spinal Cord; 2000 Apr; 38(4):211-3. PubMed ID: 10822390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating biochemical markers of bone remodeling in uremic patients.
    Ureña P; De Vernejoul MC
    Kidney Int; 1999 Jun; 55(6):2141-56. PubMed ID: 10354264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone turnover in hyperthyroidism before and after thyrostatic management.
    Isaia GC; Roggia C; Gola D; Stefano MD; Gallone G; Aimo G; Ardissone P; Mussetta M
    J Endocrinol Invest; 2000 Dec; 23(11):727-31. PubMed ID: 11194705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
    Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Pons F; Martínez de Osaba MJ; Echevarría M; Ballesta AM; Muñoz-Gómez J
    Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios.
    Carlson K; Larsson A; Simonsson B; Turesson I; Westin J; Ljunghall S
    Eur J Haematol; 1999 May; 62(5):300-6. PubMed ID: 10359057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone turnover in children with vitamin D deficiency rickets before and during treatment.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Amato V; Saggese G
    Acta Paediatr; 2000 May; 89(5):513-8. PubMed ID: 10852183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z; Jin X; Bian P; Li X; Chen J
    Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.
    Mazzaferro S; Chicca S; Pasquali M; Zaraca F; Ballanti P; Taggi F; Coen G; Cinotti GA; Carboni M
    Nephrol Dial Transplant; 2000 Jun; 15(6):877-82. PubMed ID: 10831645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
    Smilic TN; Novakovic TR; Markovic-Jovanovic SR; Smilic LLJ; Mitic JS; Radunovic ML
    J Clin Densitom; 2018; 21(3):322-328. PubMed ID: 29103946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma.
    Abildgaard N; Glerup H; Rungby J; Bendix-Hansen K; Kassem M; Brixen K; Heickendorff L; Nielsen JL; Eriksen EF
    Eur J Haematol; 2000 Feb; 64(2):121-9. PubMed ID: 10997332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer.
    Arikoski P; Komulainen J; Riikonen P; Parviainen M; Jurvelin JS; Voutilainen R; Kröger H
    J Bone Miner Res; 1999 Dec; 14(12):2002-9. PubMed ID: 10620058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
    Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y
    Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy.
    Abildgaard N; Brixen K; Kristensen JE; Eriksen EF; Nielsen JL; Heickendorff L
    Br J Haematol; 2003 Jan; 120(2):235-42. PubMed ID: 12542480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of immunoreactive bone sialoprotein in osteoporosis: positive relations to established biochemical parameters of bone turnover.
    Fassbender WJ; Ruf T; Kaiser HE; Stracke H
    In Vivo; 2000; 14(5):619-24. PubMed ID: 11125546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
    Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
    J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients.
    Fonseca R; Trendle MC; Leong T; Kyle RA; Oken MM; Kay NE; Van Ness B; Greipp PR
    Br J Haematol; 2000 Apr; 109(1):24-9. PubMed ID: 10848778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.